Not Just for Kids: Spotlight on RSV in Older Adults

Download All
Join the experts to learn about the severe clinical manifestations caused by respiratory syncytial virus in older patients. Diagnostic challenges, recent adult vaccine safety and efficacy data, and barriers to adult vaccine implementation in primary care settings will be presented. Watch the on-demand webinar, download the slides, and read the companion expert-authored ClinicalThought commentaries.
Laura Hurley, MD, MPH


RSV is underdiagnosed in older adults, and future vaccines may reduce its burden in this population. Here are my thoughts on RSV vaccine development and where the vaccines may fit in the current immunization schedule.

Laura Hurley, MD, MPH Released: September 19, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email:

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Janssen Therapeutics, Division of Janssen Products, LP

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings